203 related articles for article (PubMed ID: 37448425)
1. Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis.
Alenezi YM; Harris R; Morling J; Card T
Cureus; 2023 Jun; 15(6):e40308. PubMed ID: 37448425
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) Among Diabetic Mellitus Patients in Saudi Arabia: Systematic Review and Meta-Analysis.
Albeshry AM; Abdulrahman Alasmari M; Alshahrani JA; Alshahrani AM; Saad Almusma A; Alfaya MA; Alfaifi AJ; Alshahrani MA; Alharbi HKD; Ali Etwdi AS; Aldawsari E; Zakir Hiyat Moazam SM; Alshaiban M; Al-Harthi SN
Cureus; 2023 Dec; 15(12):e51092. PubMed ID: 38283461
[TBL] [Abstract][Full Text] [Related]
3. Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis.
Liu J; Tian Y; Fu X; Mu C; Yao M; Ni Y; Liu Y; Li Z
Chin Med J (Engl); 2022 Jul; 135(14):1682-1691. PubMed ID: 36070463
[TBL] [Abstract][Full Text] [Related]
4. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F
J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902
[TBL] [Abstract][Full Text] [Related]
5. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
Quek J; Chan KE; Wong ZY; Tan C; Tan B; Lim WH; Tan DJH; Tang ASP; Tay P; Xiao J; Yong JN; Zeng RW; Chew NWS; Nah B; Kulkarni A; Siddiqui MS; Dan YY; Wong VW; Sanyal AJ; Noureddin M; Muthiah M; Ng CH
Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.
Shalimar ; Elhence A; Bansal B; Gupta H; Anand A; Singh TP; Goel A
J Clin Exp Hepatol; 2022; 12(3):818-829. PubMed ID: 35677499
[TBL] [Abstract][Full Text] [Related]
9. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
10. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis.
En Li Cho E; Ang CZ; Quek J; Fu CE; Lim LKE; Heng ZEQ; Tan DJH; Lim WH; Yong JN; Zeng R; Chee D; Nah B; Lesmana CRA; Bwa AH; Win KM; Faulkner C; Aboona MB; Lim MC; Syn N; Kulkarni AV; Suzuki H; Takahashi H; Tamaki N; Wijarnpreecha K; Huang DQ; Muthiah M; Ng CH; Loomba R
Gut; 2023 Nov; 72(11):2138-2148. PubMed ID: 37491159
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of non-alcoholic fatty liver and its related factors in Iran: Systematic review and meta-analysis.
Chegeni M; Nili S; Darabi M; Gheysvandi E; Zahedi R; Sharifian E; Shoraka HR; Rostamkhani M; Gheshlaghi LA
J Educ Health Promot; 2023; 12():356. PubMed ID: 38144003
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Thongtan T; Deb A; Vutthikraivit W; Laoveeravat P; Mingbunjerdsuk T; Islam S; Islam E
Indian J Gastroenterol; 2022 Apr; 41(2):119-126. PubMed ID: 35318571
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.
Alswat K; Aljumah AA; Sanai FM; Abaalkhail F; Alghamdi M; Al Hamoudi WK; Al Khathlan A; Al Quraishi H; Al Rifai A; Al Zaabi M; Babatin MA; Estes C; Hashim A; Razavi H
Saudi J Gastroenterol; 2018; 24(4):211-219. PubMed ID: 29956688
[TBL] [Abstract][Full Text] [Related]
14. Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia.
Alsabaani AA; Mahfouz AA; Awadalla NJ; Musa MJ; Al Humayed SM
Int J Environ Res Public Health; 2018 Nov; 15(11):. PubMed ID: 30423871
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.
Riazi K; Azhari H; Charette JH; Underwood FE; King JA; Afshar EE; Swain MG; Congly SE; Kaplan GG; Shaheen AA
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):851-861. PubMed ID: 35798021
[TBL] [Abstract][Full Text] [Related]
16. Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.
Kummer S; Klee D; Kircheis G; Friedt M; Schaper J; Häussinger D; Mayatepek E; Meissner T
Eur J Pediatr; 2017 Apr; 176(4):529-536. PubMed ID: 28213828
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Type 2 Diabetes Mellitus in the General Population of Saudi Arabia, 2000-2020: A Systematic Review and Meta-Analysis of Observational Studies.
Jarrar M; Abusalah MAH; Albaker W; Al-Bsheish M; Alsyouf A; Al-Mugheed K; Issa MR; Alumran A
Saudi J Med Med Sci; 2023; 11(1):1-10. PubMed ID: 36909010
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait.
Sanai FM; Al Khathlan A; Al Fadhli A; Jazzar AS; Hashim AM; Mansour E; Abaalkhail F; Hasan F; Al Mudaiheem H; Al Quraishi H; Bottomley J; Alswat KA; Al Ghamdi M; Farghaly M; Fathy M; Awad N; Mohamed O; Kozma S; Al-Hamoudi W; Al-Jedai A
Hepatol Int; 2021 Aug; 15(4):912-921. PubMed ID: 33822317
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis.
Rojas YAO; Cuellar CLV; Barrón KMA; Arab JP; Miranda AL
Ann Hepatol; 2022; 27(6):100706. PubMed ID: 35427804
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
de Vries M; Westerink J; Kaasjager KHAH; de Valk HW
J Clin Endocrinol Metab; 2020 Dec; 105(12):3842-53. PubMed ID: 32827432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
